HUTCHMED (China) Ltd (HCM) Down 5.07% in Premarket Trading

Wednesday, February 14, 2024 07:30 AM | InvestorsObserver Analysts

Mentioned in this article

HUTCHMED (China) Ltd (HCM) has fallen Wednesday morning, with the stock declining -5.07% in pre-market trading to 13.3. HCM's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 105 out of 146 industries, the stock ranks higher than 55% of stocks. HUTCHMED (China) Ltd has fallen 14.94% over the past month, closing at $15.03 on January 17. During this period of time, the stock fell as low as $12.08 and as high as $15.51. HCM has an average analyst recommendation of Strong Buy. The company has an average price target of $25.54.

HCM has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on HCM!
HUTCHMED (China) Ltd has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 111 by this metric, HCM ranks better than 111% of stocks.

Important Dates for Investors in HCM:

-HUTCHMED (China) Ltd is set to release earnings on 2024-02-28. Over the last 12 months, the company has reported EPS of $-0.25. -We do not have a set dividend date for HUTCHMED (China) Ltd at this time. Click Here To Get The Full Report on HUTCHMED (China) Ltd (HCM)

Share this article: